Compare
Abbott Laboratories vs Artivion (ABT vs AORT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Artivion (AORT) -56.5%; so far this year the figures are -12.3% and -55.7%.
Abbott Laboratories is the larger company by market value, about 192.3 times the size of Artivion.
Revenue grew +10.0% at ABT and +14.0% at AORT over the last year.
ABT yields 2.29%. AORT pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | AORT | |
|---|---|---|
| Price | $109.93 | $20.21 |
| 1-day | -3.23% | -20.21% |
| YTD | -12.26% | -55.69% |
| 1 year | -11.73% | -56.55% |
| 3 years | +15.70% | +56.91% |
| Market cap | $190.4B | $990M |
| P/E | 40.9 | — |
| P/S | 3.95 | 2.05 |
| P/B | 3.73 | 2.21 |
| Revenue growth | +10.00% | +14.00% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 63.3 |
| Net margin % | 9.7 | -3.7 |
| ROE % | 9.2 | -3.9 |
| Debt / equity | 0.61 | 0.81 |
| FCF yield % | 3.5 | -4.5 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.35 |
| RSI (14) | 58.5 | 38.1 |
| Technical rating |